Optimizing Pain and Rehabilitation After Knee Arthroplasty

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Total Knee Arthroplasty
Interventions
OTHER

continuous FNB

femoral nerve block (ropivacaine 0.5%, 20 mL) with femoral nerve block infusion 48 h (ropivacaine 0.2%, 5mL/h), placebo local infiltration

OTHER

single femoral nerve block

single femoral nerve block (ropivacaine 0.5%, 20 mL), placebo femoral nerve block infusion, placebo local infiltration

OTHER

local infiltration analgesia

placebo fascia iliac block, placebo fascia iliaca infusion, local infiltration analgesia (tricompartmental injection of 150 mL ropivacaine 0.2%, ketorolac 30 mg, epinephrine 10 microg/mL)

Trial Locations (2)

L8N 4A6

St. Joseph's Healthcare Hamilton, Hamilton

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
collaborator

Canadian Anesthesiologists' Society

OTHER

collaborator

The Physicians' Services Incorporated Foundation

OTHER

lead

Sunnybrook Health Sciences Centre

OTHER

NCT01616836 - Optimizing Pain and Rehabilitation After Knee Arthroplasty | Biotech Hunter | Biotech Hunter